# ImVisioN Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imvision-therapeutics

- Industry: Biotechnology
- Headquarters: Muttenz, Switzerland
- Website: www.imvision-therapeutics.com
- Total disclosed funding: $4.5M
- Latest round: Series A (Sep 10, 2008)
- Investors on record: 2

## About

mVisioN Therapeutics is a biotechnology company that is pioneering the use of intralymphatic immunotherapy to develop safe, effective and convenient treatments for major allergies.

## Funding rounds

- Series A, Sep 10, 2008, $4.5M — Aravis, Nextech

## Investors

- Aravis (https://capitalatlas.ai/funds/aravis) — Series A
- Nextech (https://capitalatlas.ai/funds/nextech) — Series A